{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:33:58Z","timestamp":1769312038038,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"am","delay-in-days":283,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T35AA023760"],"award-info":[{"award-number":["T35AA023760"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.josat.2024.209438","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T02:03:09Z","timestamp":1717984989000},"page":"209438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial"],"prefix":"10.1016","volume":"164","author":[{"given":"Dylan Rose","family":"Balter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa B.","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Dziura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin A.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.josat.2024.209438_bb0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ADM.0000000000000931","article-title":"Revisiting the X:BOT naltrexone clinical trial using a comprehensive survival analysis","volume":"16","author":"Ajazi","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"6","key":"10.1016\/j.josat.2024.209438_bb0010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/00952990.2020.1807559","article-title":"Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff","volume":"46","author":"Andraka-Christou","year":"2020","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2024.209438_bb0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jsat.2019.06.011","article-title":"Court personnel attitudes towards medication-assisted treatment: A state-wide survey","volume":"104","author":"Andraka-Christou","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2024.209438_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugalcdep.2015.06.023","article-title":"High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants","volume":"154","author":"Barocas","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"9","key":"10.1016\/j.josat.2024.209438_bb0025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2024.209438_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1940-0640-7-3","article-title":"Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors","volume":"7","author":"Binswanger","year":"2012","journal-title":"Addiction Science & Clinical Practice"},{"issue":"2","key":"10.1016\/j.josat.2024.209438_bb0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison\u2014A high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.josat.2024.209438_bb0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/ajad.13051","article-title":"A literature review examining primary outcomes of medication treatment studies for opioid use disorder: What outcome should be used to measure opioid treatment success?","volume":"29","author":"Biondi","year":"2020","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2024.209438_bb0045","author":"Bronson"},{"issue":"8","key":"10.1016\/j.josat.2024.209438_bb0050","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/add.13803","article-title":"High risk of overdose death following release from prison: Variations in mortality during a 15-year observation period","volume":"112","author":"Bukten","year":"2017","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2024.209438_bb0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1078345816685311","article-title":"Death after jail release","volume":"23","author":"Byron Alex","year":"2017","journal-title":"Journal of Correctional Health Care"},{"issue":"2","key":"10.1016\/j.josat.2024.209438_bb0060","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2006.09.002","article-title":"Initial evidence for the reliability and validity of a \u201clite\u201d version of the addiction severity index","volume":"87","author":"Cacciola","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209438_bb0065","author":"ClinicalTrials.gov"},{"issue":"10401","key":"10.1016\/j.josat.2024.209438_bb0070","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0140-6736(23)00113-7","article-title":"Misclassification of overdose events in the X:BOT study","volume":"402","author":"Dasgupta","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"8","key":"10.1016\/j.josat.2024.209438_bb0075","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/add.12536","article-title":"The impact of opioid substitution therapy on mortality post-release from prison: Retrospective data linkage study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.josat.2024.209438_bb0080","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s11606-020-05944-6","article-title":"Barriers to medications for opioid use disorder among veterans involved in the legal system: A qualitative study","volume":"35","author":"Finlay","year":"2020","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2024.209438_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108241","article-title":"A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail","volume":"128","author":"Gordon","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2024.209438_bb0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.josat.2024.209438_bb0095","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/0033354918803938","article-title":"Linking opioid-overdose data to human services and criminal justice data: Opportunities for intervention","volume":"133","author":"Hacker","year":"2018","journal-title":"Public Health Reports"},{"issue":"13","key":"10.1016\/j.josat.2024.209438_bb0100","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials - The gold standard for effectiveness research: Study design: Randomised controlled trials","volume":"125","author":"Hariton","year":"2018","journal-title":"Bjog"},{"issue":"1","key":"10.1016\/j.josat.2024.209438_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2194-7899-1-2","article-title":"Prior criminal charges and outcomes among individuals initiating office-based buprenorphine treatment","volume":"1","author":"Harris","year":"2013","journal-title":"Health and Justice"},{"issue":"3","key":"10.1016\/j.josat.2024.209438_bb0110","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jsat.2012.08.016","article-title":"Predictors of outcome after short-term stabilization with buprenorphine","volume":"44","author":"Hillhouse","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2024.209438_bb0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11524-021-00599-y","article-title":"The stigma of criminal legal involvement and health: A conceptual framework","volume":"99","author":"Howell","year":"2022","journal-title":"Journal of Urban Health"},{"issue":"8","key":"10.1016\/j.josat.2024.209438_bb0120","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1377\/hlthaff.2020.02156","article-title":"Changes in health services use after receipt of medications for opioid use disorder in a statewide correctional system","volume":"40","author":"Howell","year":"2021","journal-title":"Health Affairs (Millwood)"},{"issue":"1","key":"10.1016\/j.josat.2024.209438_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","article-title":"A conceptual model for understanding post-release opioid-related overdose risk","volume":"14","author":"Joudrey","year":"2019","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2024.209438_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108690","article-title":"Treatment preference for opioid use disorder among people who are incarcerated","volume":"137","author":"Kaplowitz","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2024.209438_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004666","article-title":"Opioid substitution therapy as a strategy to reduce deaths in prison: Retrospective cohort study","volume":"4","author":"Larney","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.josat.2024.209438_bb0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cct.2016.08.004","article-title":"NIDA clinical trials network CTN-0051, extended-release naltrexone vs. buprenorphine for opioid treatment (X:BOT): Study design and rationale","volume":"50","author":"Lee","year":"2016","journal-title":"Contemporary Clinical Trials"},{"key":"10.1016\/j.josat.2024.209438_bb0145","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000930","article-title":"Commentary on Ajazi et al (2021) Re-analysis of the X: BOT Trial","author":"Lee","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"10401","key":"10.1016\/j.josat.2024.209438_bb0150","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(23)00049-1","article-title":"Misclassification of overdose events in the X:BOT study - Authors\u2019 reply","volume":"402","author":"Lee","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"10118","key":"10.1016\/j.josat.2024.209438_bb0155","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.josat.2024.209438_bb0160","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/aje\/kwr327","article-title":"Risks of drug-related death, suicide, and homicide during the immediate post-release period among people released from New York City jails, 2001\u20132005","volume":"175","author":"Lim","year":"2012","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1016\/j.josat.2024.209438_bb0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000313336","article-title":"Naltrexone implants compared to methadone: Outcomes six months after prison release","volume":"16","author":"Lobmaier","year":"2010","journal-title":"European Addiction Research"},{"issue":"12","key":"10.1016\/j.josat.2024.209438_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003002","article-title":"Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review","volume":"16","author":"Malta","year":"2019","journal-title":"PLoS Medicine"},{"issue":"3","key":"10.1016\/j.josat.2024.209438_bb0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1108\/IJPH-01-2020-0005","article-title":"Does criminal justice stigma affect health and health care utilization? A systematic review of public health and medical literature","volume":"16","author":"Martin","year":"2020","journal-title":"International Journal of Prisoner Health"},{"issue":"1","key":"10.1016\/j.josat.2024.209438_bb0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index","volume":"168","author":"McLellan","year":"1980","journal-title":"The Journal of Nervous and Mental Disease"},{"issue":"9","key":"10.1016\/j.josat.2024.209438_bb0185","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.josat.2024.209438_bb0190","author":"National Institute on Drug Abuse"},{"issue":"7","key":"10.1016\/j.josat.2024.209438_bb0195","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1176\/appi.ajp.2020.20060816","article-title":"Sublingual buprenorphine-naloxone compared with injection naltrexone for opioid use disorder: Potential utility of patient characteristics in guiding choice of treatment","volume":"178","author":"Nunes","year":"2021","journal-title":"The American Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.josat.2024.209438_bb0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2005.04.012","article-title":"Heroin overdose among young injection drug users in San Francisco","volume":"80","author":"Ochoa","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2024.209438_bb0205","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.drugalcdep.2018.04.034","article-title":"Beyond the walls: Risk factors for overdose mortality following release from the Philadelphia Department of Prisons","volume":"189","author":"Pizzicato","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.josat.2024.209438_bb0210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s40429-019-00283-x","article-title":"Medications for opioid use disorder among incarcerated individuals: A review of the literature and focus on patient preference","volume":"6","author":"Puglisi","year":"2019","journal-title":"Current Addiction Reports"},{"issue":"9","key":"10.1016\/j.josat.2024.209438_bb0215","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2105\/AJPH.2018.304514","article-title":"Opioid overdose mortality among former North Carolina inmates: 2000\u20132015","volume":"108","author":"Ranapurwala","year":"2018","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.josat.2024.209438_bb0220","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/08897077.2016.1220443","article-title":"Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus-positive patients","volume":"38","author":"Riggins","year":"2017","journal-title":"Substance Abuse"},{"issue":"4","key":"10.1016\/j.josat.2024.209438_bb0225","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMsr1706626","article-title":"The role of science in addressing the opioid crisis","volume":"377","author":"Volkow","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.josat.2024.209438_bb0230","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s11606-010-1306-0","article-title":"Effect of incarceration history on outcomes of primary care office-based buprenorphine\/naloxone","volume":"25","author":"Wang","year":"2010","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1016\/j.josat.2024.209438_bb0235","doi-asserted-by":"crossref","first-page":"e180558","DOI":"10.1001\/jamanetworkopen.2018.0558","article-title":"Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Network Open"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924001504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924001504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T23:31:48Z","timestamp":1728603108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924001504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":47,"alternative-id":["S2949875924001504"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209438","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209438"}}